155955-78-5

Basic information

• Product Name: 2-(3,4-DIMETHOXY-PHENYL)-N-METHOXY-N-METHYL-ACETAMIDE
• Synonyms: 2-(3,4-DIMETHOXY-PHENYL)-N-METHOXY-N-METHYL-ACETAMIDE
• CAS NO: 155955-78-5
• Molecular Formula: C₁₂H₁₇NO₄
• Molecular Weight: 239.26768
• Mol File: 155955-78-5.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-(3,4-DIMETHOXY-PHENYL)-N-METHOXY-N-METHYL-ACETAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(3,4-DIMETHOXY-PHENYL)-N-METHOXY-N-METHYL-ACETAMIDE(155955-78-5)
• EPA Substance Registry System: 2-(3,4-DIMETHOXY-PHENYL)-N-METHOXY-N-METHYL-ACETAMIDE(155955-78-5)

Safety Data

• Hazardous Substances Data: 155955-78-5(Hazardous Substances Data)

Upstream product

• 93-40-3 (3,4-Dimethoxyphenyl)acetic acid 
• 6638-79-5 N,O-dimethylhydroxylamine*hydrochloride 

Downstream Products

• 261919-88-4 1-(3,4-dimethoxyphenyl)-4-methyl-pentan-2-one 
• 884-06-0 1-(3',4'-dimethoxyphenyl)-2-butanone 
• 1026340-14-6 2-(3,4-dimethoxy-phenyl)-1-(4-dimethylamino-phenyl)-ethanone 
• 321393-93-5 2-(3,4-dimethoxy-benzyl)-3-methyl-5-phenyl-oxazolidine 
• 62717-86-6 N-[2-(3,4-dimethoxyphenyl)-1-methylethyl]-2-hydroxy-2-phenylethylamine 
• 321393-86-6 7,8-dimethoxy-4-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine 
• 321393-97-9 2-{[2-(3,4-dimethoxy-phenyl)-1-methyl-ethyl]-methyl-amino}-1-phenyl-ethanol 
• 321394-54-1 2-{[1-(3,4-dimethoxy-benzyl)-propyl]-methyl-amino}-1-phenyl-ethanol 
• 321394-42-7 2-[1-(3,4-dimethoxy-benzyl)-propylamino]-1-phenyl-ethanol 
• 321394-48-3 4-ethyl-7,8-dimethoxy-1-phenyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine 
• 321394-59-6 2-{[1-(3,4-dimethoxy-benzyl)-2-methyl-propyl]-methyl-amino}-1-phenyl-ethanol 
• 321394-52-9 4-isobutyl-7,8-dimethoxy-1-phenyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine 
• 321394-46-1 2-[1-(3,4-dimethoxy-benzyl)-3-methyl-butylamino]-1-phenyl-ethanol 
• 321394-57-4 2-{[1-(3,4-dimethoxy-benzyl)-3-methyl-butyl]-methyl-amino}-1-phenyl-ethanol 

Relevant articles and documents

Synthesis of Benzo[ b]furans by Intramolecular C-O Bond Formation Using Iron and Copper Catalysis

One-pot processes for the synthesis of benzo[b]furans from 1-aryl- or 1-alkylketones using nonprecious transition metal catalysts have been developed. Regioselective iron(III)-catalyzed halogenation of the aryl ring, followed by iron- or copper-catalyzed O-arylation allowed the synthesis of various structural analogues, including the benzo[b]furan-derived natural products corsifuran C, moracin F, and caleprunin B.

Facile o-quinodimethane formation from benzocyclobutenes triggered by the Staudinger reaction at ambient temperature

Electron-donating iminophosphoranes were found to significantly enhance 4π-ring opening of benzocyclobutenes to generate o-quinodimethanes at 20-25 °C. These iminophosphorane benzocyclobutenes can be conveniently generated from azide benzocyclobutenes and phosphines via the Staudinger reaction. Thus, Staudinger reaction-triggered sequential molecular transformations of the azide benzocyclobutenes have been established via o-quinodimethanes at ambient temperature, which is expected to exhibit potential for a wide range of applications.

Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection

The invention provides novel compounds having the general formula: wherein R1, R2, R3, R4, R5 and R6 are as described herein, compositions including the compounds and methods of using the compounds.

NOVEL DIHYDROQUINOLIZINONES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

The invention provides novel compounds having the general formula (I) wherein R1, R2 R3, R4, R5 and R6 are as described herein, compositions including the compounds and methods of using the compounds in the treatment of the hepatitis B virus.

NOVEL DIHYDROPYRIMIDIN-2(1H)-ONE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS

The present invention is directed to novel dihydropyrimidin-2(1H)-one compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.

Synthesis, structure-activity relationship, and receptor pharmacology of a new series of quinoline derivatives acting as selective, noncompetitive mGlu1 antagonists

We describe the discovery and the structure-activity relationship of a new series of quinoline derivatives acting as selective and highly potent noncompetitive mGlu1 antagonists. We first identified cis-10 as a fairly potent mGlu1 antagonist (IC50/s

5,6,7-Trisubstituted 4-Aminopyrido[2,3-d]pyrimidines as Novel Inhibitors of Adenosine Kinase

The synthesis and structure-activity relationship of a series of 5,6,7-trisubstituted 4-aminopyrido[2,3-d]pyrimidines as novel nonnucleoside adenosine kinase inhibitors is described. A variety of alkyl, aryl, and heteroaryl substituents were found to be tolerated at the C5, C6, and C7 positions of the pyridopyrimidine core. These studies have led to the identification of analogues that are potent inhibitors of adenosine kinase with in vivo analgesic activity.

5,6,7-trisubstituted-4-aminopyrido[2,3-D] pyrimidine compounds

A compound having the formula wherein R1, R2, R3, R4 and R5 are defined, a method for inhibiting adenosine kinase by administering a compound thereof, a pharmaceutical composition comprising a therapeutically effective amount of a compound thereof above i